NO324071B1 - Solution for direct application on the skin to control cattle and sheep parasites and their use. - Google Patents
Solution for direct application on the skin to control cattle and sheep parasites and their use. Download PDFInfo
- Publication number
- NO324071B1 NO324071B1 NO19975473A NO975473A NO324071B1 NO 324071 B1 NO324071 B1 NO 324071B1 NO 19975473 A NO19975473 A NO 19975473A NO 975473 A NO975473 A NO 975473A NO 324071 B1 NO324071 B1 NO 324071B1
- Authority
- NO
- Norway
- Prior art keywords
- solution
- pyrazole
- phenyl
- skin
- volume
- Prior art date
Links
- 241000283690 Bos taurus Species 0.000 title claims description 19
- 244000045947 parasite Species 0.000 title claims description 19
- 241001494479 Pecora Species 0.000 title claims description 18
- 241001465754 Metazoa Species 0.000 claims description 37
- 241000238680 Rhipicephalus microplus Species 0.000 claims description 20
- 241000238876 Acari Species 0.000 claims description 16
- 150000001875 compounds Chemical class 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 12
- -1 fatty acid esters Chemical class 0.000 claims description 9
- 241001674048 Phthiraptera Species 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 230000000694 effects Effects 0.000 claims description 7
- 238000009472 formulation Methods 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- 239000003093 cationic surfactant Substances 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 6
- 239000000194 fatty acid Substances 0.000 claims description 6
- 229930195729 fatty acid Natural products 0.000 claims description 6
- 210000004209 hair Anatomy 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 241000257161 Calliphoridae Species 0.000 claims description 5
- 239000003085 diluting agent Substances 0.000 claims description 5
- 239000004215 Carbon black (E152) Substances 0.000 claims description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- 239000004902 Softening Agent Substances 0.000 claims description 4
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical class [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims description 4
- 239000004359 castor oil Substances 0.000 claims description 4
- 235000019438 castor oil Nutrition 0.000 claims description 4
- 229920001577 copolymer Polymers 0.000 claims description 4
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 claims description 4
- 150000004665 fatty acids Chemical class 0.000 claims description 4
- 150000002191 fatty alcohols Chemical class 0.000 claims description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 4
- 229930195733 hydrocarbon Natural products 0.000 claims description 4
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- 238000003307 slaughter Methods 0.000 claims description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 3
- QZCLKYGREBVARF-UHFFFAOYSA-N Acetyl tributyl citrate Chemical compound CCCCOC(=O)CC(C(=O)OCCCC)(OC(C)=O)CC(=O)OCCCC QZCLKYGREBVARF-UHFFFAOYSA-N 0.000 claims description 3
- 239000002480 mineral oil Substances 0.000 claims description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 2
- OAYXUHPQHDHDDZ-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethanol Chemical compound CCCCOCCOCCO OAYXUHPQHDHDDZ-UHFFFAOYSA-N 0.000 claims description 2
- WMDZKDKPYCNCDZ-UHFFFAOYSA-N 2-(2-butoxypropoxy)propan-1-ol Chemical compound CCCCOC(C)COC(C)CO WMDZKDKPYCNCDZ-UHFFFAOYSA-N 0.000 claims description 2
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 claims description 2
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 claims description 2
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 claims description 2
- QCAHUFWKIQLBNB-UHFFFAOYSA-N 3-(3-methoxypropoxy)propan-1-ol Chemical compound COCCCOCCCO QCAHUFWKIQLBNB-UHFFFAOYSA-N 0.000 claims description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 claims description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 2
- OHLUUHNLEMFGTQ-UHFFFAOYSA-N N-methylacetamide Chemical compound CNC(C)=O OHLUUHNLEMFGTQ-UHFFFAOYSA-N 0.000 claims description 2
- 235000019483 Peanut oil Nutrition 0.000 claims description 2
- 239000004264 Petrolatum Substances 0.000 claims description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 claims description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 2
- 235000019486 Sunflower oil Nutrition 0.000 claims description 2
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 125000001931 aliphatic group Chemical group 0.000 claims description 2
- 150000005215 alkyl ethers Chemical class 0.000 claims description 2
- 150000008051 alkyl sulfates Chemical class 0.000 claims description 2
- 239000002280 amphoteric surfactant Substances 0.000 claims description 2
- 239000003945 anionic surfactant Substances 0.000 claims description 2
- 150000001450 anions Chemical class 0.000 claims description 2
- JPNZKPRONVOMLL-UHFFFAOYSA-N azane;octadecanoic acid Chemical class [NH4+].CCCCCCCCCCCCCCCCCC([O-])=O JPNZKPRONVOMLL-UHFFFAOYSA-N 0.000 claims description 2
- 229960003237 betaine Drugs 0.000 claims description 2
- 235000013539 calcium stearate Nutrition 0.000 claims description 2
- 239000008116 calcium stearate Substances 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 239000003240 coconut oil Substances 0.000 claims description 2
- 235000019864 coconut oil Nutrition 0.000 claims description 2
- 235000005687 corn oil Nutrition 0.000 claims description 2
- 239000002285 corn oil Substances 0.000 claims description 2
- 235000012343 cottonseed oil Nutrition 0.000 claims description 2
- 239000002385 cottonseed oil Substances 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 claims description 2
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 claims description 2
- 229940031769 diisobutyl adipate Drugs 0.000 claims description 2
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 claims description 2
- YHAIUSTWZPMYGG-UHFFFAOYSA-L disodium;2,2-dioctyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCCC YHAIUSTWZPMYGG-UHFFFAOYSA-L 0.000 claims description 2
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 claims description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- 229940100242 glycol stearate Drugs 0.000 claims description 2
- 150000002334 glycols Chemical class 0.000 claims description 2
- 239000008169 grapeseed oil Substances 0.000 claims description 2
- 150000004820 halides Chemical class 0.000 claims description 2
- RNYJXPUAFDFIQJ-UHFFFAOYSA-N hydron;octadecan-1-amine;chloride Chemical class [Cl-].CCCCCCCCCCCCCCCCCC[NH3+] RNYJXPUAFDFIQJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000000787 lecithin Substances 0.000 claims description 2
- 235000010445 lecithin Nutrition 0.000 claims description 2
- 229940067606 lecithin Drugs 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000002736 nonionic surfactant Substances 0.000 claims description 2
- ZHALDANPYXAMJF-UHFFFAOYSA-N octadecanoate;tris(2-hydroxyethyl)azanium Chemical compound OCC[NH+](CCO)CCO.CCCCCCCCCCCCCCCCCC([O-])=O ZHALDANPYXAMJF-UHFFFAOYSA-N 0.000 claims description 2
- 239000004006 olive oil Substances 0.000 claims description 2
- 235000008390 olive oil Nutrition 0.000 claims description 2
- 239000012188 paraffin wax Substances 0.000 claims description 2
- 239000000312 peanut oil Substances 0.000 claims description 2
- 235000019271 petrolatum Nutrition 0.000 claims description 2
- 229940066842 petrolatum Drugs 0.000 claims description 2
- 229920000223 polyglycerol Polymers 0.000 claims description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 2
- 229920001296 polysiloxane Polymers 0.000 claims description 2
- 229920000053 polysorbate 80 Polymers 0.000 claims description 2
- 229940068968 polysorbate 80 Drugs 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 2
- 229920002545 silicone oil Polymers 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 2
- 229940080236 sodium cetyl sulfate Drugs 0.000 claims description 2
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 claims description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 2
- ITCAUAYQCALGGV-XTICBAGASA-M sodium;(1r,4ar,4br,10ar)-1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylate Chemical compound [Na+].C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C([O-])=O ITCAUAYQCALGGV-XTICBAGASA-M 0.000 claims description 2
- GGHPAKFFUZUEKL-UHFFFAOYSA-M sodium;hexadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCOS([O-])(=O)=O GGHPAKFFUZUEKL-UHFFFAOYSA-M 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 235000010356 sorbitol Nutrition 0.000 claims description 2
- 235000012424 soybean oil Nutrition 0.000 claims description 2
- 239000002600 sunflower oil Substances 0.000 claims description 2
- 229940029614 triethanolamine stearate Drugs 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 239000008158 vegetable oil Substances 0.000 claims description 2
- 239000003549 soybean oil Substances 0.000 claims 1
- 150000003626 triacylglycerols Chemical class 0.000 claims 1
- 229940126062 Compound A Drugs 0.000 description 15
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 15
- 238000000034 method Methods 0.000 description 7
- 229940068196 placebo Drugs 0.000 description 7
- 239000000902 placebo Substances 0.000 description 7
- 241000255925 Diptera Species 0.000 description 4
- 239000002917 insecticide Substances 0.000 description 4
- YXWCBRDRVXHABN-JCMHNJIXSA-N [cyano-(4-fluoro-3-phenoxyphenyl)methyl] 3-[(z)-2-chloro-2-(4-chlorophenyl)ethenyl]-2,2-dimethylcyclopropane-1-carboxylate Chemical compound C=1C=C(F)C(OC=2C=CC=CC=2)=CC=1C(C#N)OC(=O)C1C(C)(C)C1\C=C(/Cl)C1=CC=C(Cl)C=C1 YXWCBRDRVXHABN-JCMHNJIXSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 208000006123 Myiasis Diseases 0.000 description 2
- 230000002141 anti-parasite Effects 0.000 description 2
- 239000003096 antiparasitic agent Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000000749 insecticidal effect Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- NMRPBPVERJPACX-UHFFFAOYSA-N octan-3-ol Chemical compound CCCCCC(O)CC NMRPBPVERJPACX-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000009304 pastoral farming Methods 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 230000000384 rearing effect Effects 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- WITMXBRCQWOZPX-UHFFFAOYSA-N 1-phenylpyrazole Chemical class C1=CC=NN1C1=CC=CC=C1 WITMXBRCQWOZPX-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241000238678 Boophilus Species 0.000 description 1
- 241000122995 Cynipoidea Species 0.000 description 1
- 241000202828 Dermatobia hominis Species 0.000 description 1
- 241000257224 Haematobia Species 0.000 description 1
- 241001113970 Linognathus Species 0.000 description 1
- 241000257166 Lucilia cuprina Species 0.000 description 1
- 241000736227 Lucilia sericata Species 0.000 description 1
- 241000403354 Microplus Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241001649230 Psoroptes ovis Species 0.000 description 1
- 241000509427 Sarcoptes scabiei Species 0.000 description 1
- 241000190070 Sarracenia purpurea Species 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 244000000054 animal parasite Species 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 238000012824 chemical production Methods 0.000 description 1
- 238000005056 compaction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229940057917 medium chain triglycerides Drugs 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 150000003217 pyrazoles Chemical class 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 125000005372 silanol group Chemical group 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having no bond to a nitrogen atom
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- General Health & Medical Sciences (AREA)
- Environmental Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Description
Den foreliggende oppfinnelse vedrører en oppløsning for direkte påhelling på huden som inneholder et anti-parasittisk produkt og er tiltenkt å tilføres topisk til kveg og sauer. The present invention relates to a solution for direct application to the skin which contains an anti-parasitic product and is intended to be applied topically to cattle and sheep.
Oppfinnelsen vedrører også anvendelse av anti-parasittiske forbindelser for fremstilling av denne oppløsningen for hud. The invention also relates to the use of anti-parasitic compounds for the preparation of this solution for skin.
Kveg og sauer rammes av et stort antall parasitter. Cattle and sheep are affected by a large number of parasites.
De vesentligste er midd av slekten Boophilus, og blant disse kan det nevnes artene microplus (kveg-midd), dekoloratus og anulatus. The most important are mites of the genus Boophilus, and among these the species microplus (cattle mite), decoloratus and anulatus can be mentioned.
De andre vesentlige parasitter hos kveg og sauer er indikert i rekkefølge med avtagende viktighet: - myiasis slik som Dermatobia hominis (kjent som Berne i Brazil) og Cochlyomia hominivorax (gullflue), saue-myiasis slik som Lucilia sericata, Lucilia cuprina (kjent som brun fluesnapper i The other important parasites of cattle and sheep are indicated in order of decreasing importance: - myiasis such as Dermatobia hominis (known as Berne in Brazil) and Cochlyomia hominivorax (gold fly), ovine myiasis such as Lucilia sericata, Lucilia cuprina (known as brown flycatcher i
Australia, New Zealand og Syd Afrika). Dette er fluer hvis larve utgjør dyreparasitten. særegne fluer, nemlig dem hvor voksne individer utgjør parasitten, slik som Haematobia Australia, New Zealand and South Africa). These are flies whose larvae form the animal parasite. peculiar flies, namely those where adult individuals constitute the parasite, such as Haematobia
irritans (liten stikkflue). irritans (small stinging fly).
lus slik som Linognathus vitulorum, etc. lice such as Linognathus vitulorum, etc.
gallveps slik som Sarcoptes scabiei og Psoroptes ovis. gall wasps such as Sarcoptes scabiei and Psoroptes ovis.
Midd, særlig Boophilus microplus, er svært nær knyttet til det beiteområde som de lever i og er særlig vanskelig å kontrollere. Mites, in particular Boophilus microplus, are very closely linked to the grazing area in which they live and are particularly difficult to control.
Det er for tiden ingen virkelig effektiv metode for å kontrollere midd, og enda mindre en effektiv måte til å kontrollere de parasitter som er angitt i det foregående. There is currently no truly effective method of controlling mites, much less an effective way to control the parasites listed above.
WO-A-87/3781, EP-A-295.117 og EP-A-500.209 beskriver en klasse insekticider som er N-fenylpyrazol-derivater. Disse forbindelsene er angitt å ha aktivitet mot et svært stort antall parasitter, inkluderende Boophilus microplus, innen områder så varierte som agrikultur, folkehelse og veterinærmedisin. Den generelle lære i disse publikasjonene indikerer at disse insekticide forbindelser kan administreres via forskjellige ruter slik som orale, parenterale, perkutane og topiske ruter. Topisk administrering omfatter særlig orale formuleringer, lokkemat, kosttillegg, hud-oppløsninger (for påhelling), oppløsninger for sprøyting (sprayer), bad, dusjer, spruter, pulvere, innfettingsmidler, sjampoer, kremer etc. Oppløsninger av den type som skal helles på huden er utformet for perkutan administrering. Eksempel 9 i EP-A-295.117 og eksempel 29I i EP-A-500.209 beskriver en oppløsning av den type som helles på huden inneholdende 15% insekticid og 85% dimetylsulfoksyd, for perkutan administrering av insekticidet. WO-A-87/3781, EP-A-295,117 and EP-A-500,209 describe a class of insecticides which are N-phenylpyrazole derivatives. These compounds have been reported to have activity against a very large number of parasites, including Boophilus microplus, in areas as diverse as agriculture, public health and veterinary medicine. The general teachings of these publications indicate that these insecticidal compounds can be administered by various routes such as oral, parenteral, percutaneous and topical routes. Topical administration includes in particular oral formulations, baits, dietary supplements, skin solutions (for application), solutions for spraying (sprays), baths, showers, syringes, powders, greasers, shampoos, creams, etc. Solutions of the type to be poured onto the skin is designed for percutaneous administration. Example 9 in EP-A-295,117 and Example 29I in EP-A-500,209 describe a solution of the type that is poured onto the skin containing 15% insecticide and 85% dimethylsulfoxide, for percutaneous administration of the insecticide.
EP-A-296.381 beskriver også pyrazolforbindelser med insekticid aktivitet innen områdene agrikultur, folkehelse og veterinærmedisin. Boophilus microplus er en av de svært mange mål som nevnes. Det er svært mange former for administrering her også, og disse inkluderer f.eks. oppløsninger, emulsjoner, suspensjoner, pulvere, pastaer, granuler og aerosoler. EP-A-296,381 also describes pyrazole compounds with insecticidal activity in the fields of agriculture, public health and veterinary medicine. Boophilus microplus is one of the many targets mentioned. There are many forms of administration here too, and these include e.g. solutions, emulsions, suspensions, powders, pastes, granules and aerosols.
Det problem som fremsettes er å finne et effektivt middel som er fullt ut egnet for å kontrollere parasittene hos kveg og sauer, særlig midd, mest spesielt Boophilus microplus i kveg og særlig lus og spyflue i sauer, under de forhold som disse dyrene oppdrettes under. The problem presented is to find an effective agent which is fully suitable for controlling the parasites in cattle and sheep, especially mites, most especially Boophilus microplus in cattle and especially lice and blowflies in sheep, under the conditions under which these animals are reared.
Det er i oppfinnelsens sammenheng funnet at det er mulig å effektivt kontrollere Boophilus microplus for kveg ved anvendelse av en spesifikk topisk formulering. Det er i oppfinnelsens sammenheng også funnet at denne formuleringen er effektiv mot sauelus og sauefluer kjent som "spyfluer". In the context of the invention, it has been found that it is possible to effectively control Boophilus microplus in cattle by using a specific topical formulation. In the context of the invention, it has also been found that this formulation is effective against sheep lice and sheep flies known as "spit flies".
Formålet for den foreliggende oppfinnelse er således å tilveiebringe et nytt preparat som er fullt ut effektivt mot Boophilus microplus og også mot alle de andre parasittene som er beskrevet i det foregående, særlig slik som sauelus og "spyfluer", idet dette preparatet er fullt ut egnet for å kontrollere disse parasittene under de forhold som disse dyrene oppdrettes under. The purpose of the present invention is thus to provide a new preparation which is fully effective against Boophilus microplus and also against all the other parasites described in the foregoing, particularly such as sheep lice and "spitflies", as this preparation is fully suitable to control these parasites under the conditions in which these animals are reared.
Et annet mål for oppfinnelsen er å tilveiebringe en slik formulering som har en lang virkningsperiode, foretrukket lengre enn eller lik 2 måneder. Another aim of the invention is to provide such a formulation which has a long period of action, preferably longer than or equal to 2 months.
Et annet mål for oppfinnelsen er å tilveiebringe en slik formulering som er rask og enkel å anvende og fullt ut forenlig med anvendelse på buskaper eller flokker som inneholder et stort antall dyr. Another aim of the invention is to provide such a formulation which is quick and easy to use and fully compatible with use on livestock or herds containing a large number of animals.
Et annet mål for oppfinnelsen er å tilveiebringe en slik formulering som er særlig egnet for ekstensivt oppdrett på beite og for anvendelse tiltenkt å beskytte dyr under perioden med sammendriving av bøling og ferdigbehandling (Feed Lot i USA), nemlig den siste perioden av oppdrett hvori et stort antall dyr drives sammen i en liten innhegning over en gjennomsnittlig periode på 2 måneder før slakting. Another aim of the invention is to provide such a formulation which is particularly suitable for extensive rearing on pasture and for use intended to protect animals during the period of compaction and finishing (Feed Lot in the USA), namely the last period of rearing in which a large numbers of animals are run together in a small enclosure over an average period of 2 months before slaughter.
Formålet for den foreliggende oppfinnelse er således en oppløsning for direkte påhelling på huden, tiltenkt for å fjerne parasitter fra kveg og sauer, mest spesielt midd, særlig Boophilus microplus hos kveg og lus og spyflue hos sauer, omfattende fra 0,1 til 2% vekt/volum, i forhold til den totale oppløsning, av en forbindelse (A): 1-[2,6-CI2-4-CF3-fenyl]-3-CN-4-[SO-CF3]-5-NH2-pyrazol i en formulering med lite volum, utformet til å frigi forbindelsen (A) på huden og hårene for en kontaktvirkning mot parasittene. The purpose of the present invention is thus a solution for direct application to the skin, intended to remove parasites from cattle and sheep, most especially mites, especially Boophilus microplus in cattle and lice and blowflies in sheep, comprising from 0.1 to 2% by weight /volume, relative to the total solution, of a compound (A): 1-[2,6-CI2-4-CF3-phenyl]-3-CN-4-[SO-CF3]-5-NH2-pyrazole in a low volume formulation designed to release compound (A) on the skin and hairs for a contact action against the parasites.
Lave konsentrasjoner på fra 0,1 til 2% er foretrukket. Optimalt er verdien mellom 0,25 og 1,5%, særlig i området 1%. Low concentrations of from 0.1 to 2% are preferred. Optimally, the value is between 0.25 and 1.5%, especially in the range of 1%.
Uttrykket oppløsning for påhelling på hud forståes å referere til en klar-til-bruk oppløsning tiltenkt å tilføres topisk og lokalt på dyret, foretrukket på dyrets rygg og ved flere punkter eller langs rygglinjen, og tilført i lite volum, foretrukket 5 til 20 ml pr. 100 kg, foretrukket omtrent 10 ml pr. 100 kg, med et totalt volum på fra 10 til 150 ml pr. dyr, foretrukket begrenset til 50 ml. The term solution for application to the skin is understood to refer to a ready-to-use solution intended to be applied topically and locally to the animal, preferably on the animal's back and at several points or along the dorsal line, and applied in a small volume, preferably 5 to 20 ml per . 100 kg, preferably approximately 10 ml per 100 kg, with a total volume of from 10 to 150 ml per animals, preferably limited to 50 ml.
Forbindelsen virker ved enkel kontakt, idet parasitten blir impregnert med forbindelsen ved kontakt med håret og huden. The compound works by simple contact, as the parasite becomes impregnated with the compound on contact with the hair and skin.
Dette frembyr derfor på en bemerkelsesverdig måte en både perfekt forlikelighet med begrensningene ved bruk i ekstensiv gressing, særlig hva angår enkelhet ved bruk, og et spektrum av aktivitet og virkningsfullhet, såvel som en virkningsperiode, som er egnet for denne type oppdrett. This therefore offers in a remarkable way both a perfect compatibility with the limitations of use in extensive grazing, particularly with regard to ease of use, and a spectrum of activity and effectiveness, as well as a period of effectiveness, which is suitable for this type of farming.
Ved å utnytte konsentrasjonen av forbindelse A, oppnås oppløsninger med bemerkelsesverdige aktiviteter med særlig to måneder virkningsfullhet mot Boophilus microplus, idet et slikt resultat aldri tidligere er blitt oppnådd. Oppløsningen i samsvar med oppfinnelsen lar dessuten Boophilus microplus fjernes fullstendig fra et infisert dyr på mindre enn 2 dager. By exploiting the concentration of compound A, solutions with remarkable activities are obtained with particularly two months of effectiveness against Boophilus microplus, such a result having never been achieved before. The solution according to the invention also allows Boophilus microplus to be completely removed from an infected animal in less than 2 days.
Som angitt i det foregående tilføres oppløsningen i samsvar med oppfinnelsen topisk, i lite volum, til dyrets rygg. Forbindelsen (A) spres deretter ut på en bemerkelsesverdig måte, hvilket gir seg uttrykk ved en fordeling av forbindelsen over hele dyrets kropp. Det er også blitt observert at dyrene forblir beskyttet i tilfelle de beveger seg gjennom vann eller utsettes for regn. As indicated above, the solution according to the invention is applied topically, in a small volume, to the animal's back. The compound (A) is then spread out in a remarkable way, which is expressed by a distribution of the compound over the whole body of the animal. It has also been observed that the animals remain protected in case they move through water or are exposed to rain.
Dosen av forbindelse (A) er foretrukket mellom 0,1 og 2 mg/kg (vekt av dyr), foretrukket mellom 0,25 og 1,5 mg/kg, og særlig omtrent 1 mg/kg. The dose of compound (A) is preferably between 0.1 and 2 mg/kg (weight of animal), preferably between 0.25 and 1.5 mg/kg, and especially about 1 mg/kg.
Forbindelsen A vil særlig anvendes i et forhold på fra 0,1 til 2 vekt%, mer spesielt omtrent 1 vekt%, i forhold til den totale oppløsningen. The compound A will in particular be used in a ratio of from 0.1 to 2% by weight, more particularly about 1% by weight, in relation to the total solution.
Forbindelsen (A) kan fremstilles i samsvar med en eller annen av de prosesser som beskrives i patentsøknader WO-A-87/3781, 93/6089, 94/21606 eller europeisk patentsøknad EP-A-0.295.117, eller en hvilken som helst annen prosess som ligger innenfor kunnskapene til en spesialist innen området kjemisk syntese. For kjemisk fremstilling av produktene i samsvar med oppfinnelsen betraktes en fagkyndig innen området å ha til sin disposisjon bl.a. hele innholdet i "Chemical Abstracts" og de publikasjoner som er angitt deri. The compound (A) may be prepared in accordance with any of the processes described in patent applications WO-A-87/3781, 93/6089, 94/21606 or European patent application EP-A-0,295,117, or any other process which is within the knowledge of a specialist in the field of chemical synthesis. For the chemical production of the products in accordance with the invention, an expert in the field is considered to have at his disposal, among other things the entire contents of "Chemical Abstracts" and the publications listed therein.
Det avviker ikke fra rammen av den foreliggende oppfinnelse å innlemme andre insekticider i oppløsningen i samsvar med den foreliggende oppfinnelse. It does not deviate from the scope of the present invention to incorporate other insecticides into the solution in accordance with the present invention.
Oppløsningene i samsvar med oppfinnelsen, som fordelaktig er oljeaktige, omfatter generelt et fortynningsmiddel eller bærer og også et løsningsmiddel (organisk løsningsmiddel) for forbindelsen The solutions according to the invention, which are advantageously oily, generally comprise a diluent or carrier and also a solvent (organic solvent) for the compound
(A) hvis sistnevnte ikke er oppløselig i fortynningsmiddelet. (A) if the latter is not soluble in the diluent.
Som organisk løsningsmiddel som kan anvendes i oppfinnelsen kan det særlig nevnes: acetyltributylsitrat, fettsyreestere slik som dimetylester, diisobutyladipat, aceton, acetonitril, benzylalkohol, butyldiglykol, dimetylacetamid, dimetylformamid, dipropylenglykol-n-butyleter, etanol, isopropanol, metanol, etylenglykol-monoetyleter, etylenglykol-monometyleter, monometylacetamid, dipropylenglykol-monometyleter, flytende polyoksyetylenglykoler, propylenglykol, 2-pyrrolidon, særlig N-metylpyrrolidon, dietylenglykol-monoetyleter, etylenglykol og dietylftalat, eller en blanding av minst to av disse løsningsmidler. As an organic solvent that can be used in the invention, the following can be mentioned in particular: acetyl tributyl citrate, fatty acid esters such as dimethyl ester, diisobutyl adipate, acetone, acetonitrile, benzyl alcohol, butyl diglycol, dimethylacetamide, dimethylformamide, dipropylene glycol-n-butyl ether, ethanol, isopropanol, methanol, ethylene glycol monoethyl ether, ethylene glycol monomethyl ether, monomethyl acetamide, dipropylene glycol monomethyl ether, liquid polyoxyethylene glycols, propylene glycol, 2-pyrrolidone, especially N-methylpyrrolidone, diethylene glycol monoethyl ether, ethylene glycol and diethyl phthalate, or a mixture of at least two of these solvents.
Som bærer eller fortynningsmiddel kan det særlig nevnes: As a carrier or diluent, the following can be mentioned in particular:
planteoljer slik som soyaolje, jordnøttolje, ricinusolje, maisolje, bomullsfrøolje, olivenolje, druekjerneolje, solsikkeolje etc, mineraloljer slik som petrolatum, paraffin, silikon etc, alifatiske eller cykliske hydrokarboner eller alternativt f.eks. triglycerider med middels kjedelengde (særlig C8 til C12). vegetable oils such as soya oil, peanut oil, castor oil, corn oil, cotton seed oil, olive oil, grape seed oil, sunflower oil etc, mineral oils such as petrolatum, paraffin, silicone etc, aliphatic or cyclic hydrocarbons or alternatively e.g. medium chain triglycerides (especially C8 to C12).
Et bløtgjøringsmiddel og/eller utsprøytningsmiddel og/eller filmdanningsmiddel vil foretrukket tilsettes, idet dette middelet særlig velges fra: - polyvinylpyrrolidon, polyvinylalkoholer, kopolymerer av vinylacetat og vinylpyrrolidon, polyetylenglykoler, benzylalkohol, mannitol, glycerol, sorbitol, polyoksyetylenerte sorbitanestere, lecitin, natriumkarboksymetylcellulose, silikonoljer, polydiorganosiloksanoljer, særlig polydimetyl-siloksan (PDMS) oljer, f.eks. dem inneholdende silanol-funksjonaliteter, eller en 45V2 olje, - anioniske surfaktanter slik som alkaliske stearater, særlig natrium-, kalium- eller ammoniumstearater, kalsiumstearat, trietanolaminstearat, natriumabietat, alkylsulfater, særlig natriumlaurylsulfat og natriumcetylsulfat, natriumdodekylbenzensulfonat, A softening agent and/or spraying agent and/or film-forming agent will preferably be added, this agent being particularly selected from: - polyvinylpyrrolidone, polyvinyl alcohols, copolymers of vinyl acetate and vinylpyrrolidone, polyethylene glycols, benzyl alcohol, mannitol, glycerol, sorbitol, polyoxyethylene sorbitan esters, lecithin, sodium carboxymethyl cellulose, silicone oils , polydiorganosiloxane oils, especially polydimethylsiloxane (PDMS) oils, e.g. those containing silanol functionalities, or a 45V2 oil, - anionic surfactants such as alkaline stearates, especially sodium, potassium or ammonium stearates, calcium stearate, triethanolamine stearate, sodium abietate, alkyl sulfates, especially sodium lauryl sulfate and sodium cetyl sulfate, sodium dodecylbenzenesulfonate,
natriumdioktylsulfosuccinat, fettsyrer, særlig dem avledet fra kokosnøttolje, sodium dioctyl sulfosuccinate, fatty acids, especially those derived from coconut oil,
- kationiske surfaktanter slik som vannoppløselige kvaternære ammoniumsalter med formel N+R'R"R'"R""1 Y" hvori radikalene R er eventuelt hydroksylerte hydrokarbonradikaler og Y" er et anion av en sterk syre slik som halogenid-, sulfat- og sulfonatanioner, idet - cationic surfactants such as water-soluble quaternary ammonium salts with the formula N+R'R"R'"R""1 Y" in which the radicals R are possibly hydroxylated hydrocarbon radicals and Y" is an anion of a strong acid such as halide, sulfate and sulfonate anions, ie
cetyltrimetylammoniumbromid er blant de kationiske surfaktanter som kan anvendes, cetyltrimethylammonium bromide is among the cationic surfactants that can be used,
- aminsalter med formel N<+>R'R"R'" hvori radikalene R er eventuelt hydroksylerte hydrokarbonradikaler, idet oktadekylamin-hydroklorid er blant de kationiske surfaktanter som kan anvendes, - ikke-ioniske surfaktanter slik som sorbitanestere, som eventuelt er polyoksyetylenerte, særlig Polysorbate 80, polyoksyetylenerte alkyletere, polyoksypropylerte fettalkoholer slik som polyoksypropylen-styroleter, polyetylenglykolstearat, polyoksyetylenerte derivater av ricinusolje, polyglycerolestere, polyoksyetylenerte fettalkoholer, polyoksyetylenerte fettsyrer, kopolymerer av etylenoksyd og propylenoksyd, - amine salts with the formula N<+>R'R"R'" in which the radicals R are optionally hydroxylated hydrocarbon radicals, octadecylamine hydrochloride being among the cationic surfactants that can be used, - non-ionic surfactants such as sorbitan esters, which are optionally polyoxyethylenated, in particular Polysorbate 80, polyoxyethylenated alkyl ethers, polyoxypropylated fatty alcohols such as polyoxypropylene styrene ethers, polyethylene glycol stearate, polyoxyethylenated derivatives of castor oil, polyglycerol esters, polyoxyethylenated fatty alcohols, polyoxyethylenated fatty acids, copolymers of ethylene oxide and propylene oxide,
- amfotære surfaktanter slik som substituerte laurylforbindelser av betain, - amphoteric surfactants such as substituted lauryl compounds of betaine,
eller en blanding av minst to av disse midlene. or a mixture of at least two of these agents.
Løsningsmiddelet vil anvendes i forhold til konsentrasjonen av forbindelsen (A) og oppløseligheten derav i dette løsningsmiddelet. The solvent will be used in relation to the concentration of the compound (A) and its solubility in this solvent.
For eksempel har forbindelse A en oppløselighet på 4,3% mA/ i acetyltributylcitrat. Det vil forsøkes å ha det lavest mulige volum. For example, compound A has a solubility of 4.3% mA/ in acetyltributyl citrate. An attempt will be made to have the lowest possible volume.
Bæreren utgjør forskjellen til 100%. The carrier makes up the difference to 100%.
Bløtgjøringsmiddelet anvendes foretrukket i et forhold på fra 0,1 til 10 volum%, særlig fra 0,25 til 5 volum%. The softening agent is preferably used in a ratio of from 0.1 to 10% by volume, in particular from 0.25 to 5% by volume.
Den foreliggende oppfinnelse kan anvendes i en fremgangsmåte for å fjerne parasitter, særlig Boophilus microplus, fra kveg og sauer ved anvendelse av en oppløsning for direkte påhelling på hud i samsvar med den foreliggende oppfinnelse, for å oppnå langvarig og bredspektrum-virkningsfullhet, idet oppløsningen tilføres til dyrets rygg, foretrukket langs rygglinjen ved ett eller flere punkter. The present invention can be used in a method for removing parasites, in particular Boophilus microplus, from cattle and sheep using a solution for direct application to the skin in accordance with the present invention, in order to achieve long-term and broad-spectrum effectiveness, the solution being supplied to the animal's back, preferably along the back line at one or more points.
Fremgangsmåten består i å tilføre oppløsningen til dyrene på beite og/eller før de kommer til beite, idet tilføringen foretrukket gjentas hver måned, foretrukket hver 2. måned. The method consists in adding the solution to the animals on pasture and/or before they come to pasture, the addition being preferably repeated every month, preferably every 2 months.
Oppløsningen tilføres fortrinsvis til dyrene før de kommer til "Feed Lot", idet det er mulig at denne tilføringen er den siste før dyrene slaktes. The solution is preferably added to the animals before they arrive at the "Feed Lot", as it is possible that this addition is the last before the animals are slaughtered.
Fremgangsmåten kan åpenbart også bestå av en kombinasjon av disse to utførelsesformene, nemlig den første etterfulgt av den andre. The method can obviously also consist of a combination of these two embodiments, namely the first followed by the second.
I alle tilfeller gjør virkningsfullheten det på fordelaktig måte mulig å stoppe enhver tilføring 1 til 3 måneder før slakting, særlig mellom 1,5 og 2,5 måneder, mer spesielt omtrent 2 måneder før slakting. In any case, the effectiveness advantageously allows any supply to be stopped 1 to 3 months before slaughter, particularly between 1.5 and 2.5 months, more particularly about 2 months before slaughter.
Oppløsningene i samsvar med oppfinnelsen kan tilføres ved anvendelse av et hvilket som helst i og for seg kjent middel, foretrukket ved anvendelse av en applikator-trykksprøyte eller en målekolbe. The solutions in accordance with the invention can be supplied using any means known per se, preferably using an applicator pressure syringe or a measuring flask.
Målet med metoden er særlig å rengjøre huden og hårene til dyrene ved å fjerne de parasitter som er tilstede derpå, såvel som deres rester og avføring. Resultatet av dette er at dyrene ikke lengre stresses av parasittene og deres bitt, hvilket har positive følger f.eks. for deres vekst og på anvendelsen av deres matrasjon. The aim of the method is particularly to clean the skin and hair of the animals by removing the parasites present thereon, as well as their remains and faeces. The result of this is that the animals are no longer stressed by the parasites and their bites, which has positive consequences, e.g. for their growth and on the application of their nutrition.
Gjenstanden for den foreliggende oppfinnelse er også anvendelse av forbindelse A for fremstilling av en oppløsning for direkte påhelling på huden i et lite volum og som er utformet til å frigjøre forbindelsen (A) på huden og hårene for en kontaktvirkning mot parasittene hos kveg og sauer, særlig midd hos kveg, slik som Boophilus microplus, og spyfluer og lus hos sauer. The object of the present invention is also the use of compound A for the preparation of a solution for direct application to the skin in a small volume and which is designed to release the compound (A) on the skin and hairs for a contact effect against the parasites in cattle and sheep, especially mites in cattle, such as Boophilus microplus, and blowflies and lice in sheep.
Anvendelsen i samsvar med oppfinnelsen er rettet mot fremstilling av hud-oppløsninger som beskrevet i det foregående. The application in accordance with the invention is aimed at the production of skin solutions as described above.
Den foreliggende oppfinnelse vil nå beskrives mer detaljert med hjelp av ikke-begrensende utførelseseksempler som demonstrerer aktiviteten av oppløsningene i samsvar med den foreliggende oppfinnelse, med referanse til de vedføyde tegninger hvori: Fig. 1 er et diagram som viser virkningsfullheten, mot Boophilus microplus, av hud-oppløsninger i samsvar med oppfinnelsen med et innhold på 0,25%, 0,5% og 1%, i forhold til en kontroll, idet denne grafen inkluderer på x-aksen tiden i dager etter tilføring av hud-oppløsningene og, på y-aksen til venstre, antallet midd talt på dyrene som hud-oppløsningene i samsvar med oppfinnelsen er tilført på og, på y-aksen til høyre, antallet midd talt i kontrollene, Fig. 2 er et diagram som viser populasjonen av midd i dyr som har mottatt placebo i samsvar med eksempel 2, med tiden i dager på x-aksen og antallet midd på y-aksen, og Fig. 3 sammenligner virkningsfullheten av en hud-oppløsning i samsvar med oppfinnelsen inneholdende 1% forbindelse A (fylte sirkler) med en hud-oppløsning inneholdende 1% flumetrin (ringer), med tiden i dager på x-aksen og antallet midd på y-aksen. The present invention will now be described in more detail by means of non-limiting examples of embodiments which demonstrate the activity of the solutions in accordance with the present invention, with reference to the attached drawings in which: Fig. 1 is a diagram showing the effectiveness, against Boophilus microplus, of skin solutions in accordance with the invention with a content of 0.25%, 0.5% and 1%, in relation to a control, this graph including on the x-axis the time in days after administration of the skin solutions and, on the y-axis on the left, the number of mites counted on the animals to which the skin solutions according to the invention are applied and, on the y-axis on the right, the number of mites counted in the controls, Fig. 2 is a diagram showing the population of mites in animals who have received placebo according to example 2, with time in days on the x-axis and the number of mites on the y-axis, and Fig. 3 compares the effectiveness of a skin solution according to the invention containing 1% compound A (filled say rkler) with a skin solution containing 1% flumethrin (rings), with time in days on the x-axis and the number of mites on the y-axis.
Eksempel 1: Fremstilling av oppløsningene i samsvar med oppfinnelsen. Example 1: Preparation of the solutions in accordance with the invention.
Forbindelse A fortynnes i løsningsmiddelet før den blandes med de andre bestanddelene. Compound A is diluted in the solvent before mixing with the other ingredients.
Eksempel 2: Example 2:
Undersøkelse av virkningsfullheten av hud-oppløsninger i samsvar med oppfinnelsen inneholdende henholdsvis 0,25, 0,50 og 1% forbindelse A for å bekjempe Boophilus microplus. Examination of the effectiveness of skin solutions according to the invention containing respectively 0.25, 0.50 and 1% compound A to combat Boophilus microplus.
Undersøkelsen ble utført på 16 unge kastrerte Hereford-okser (vekt i området mellom 114 og 172 kg). The investigation was carried out on 16 young castrated Hereford bulls (weight in the range between 114 and 172 kg).
Tre hud-oppløsninger i samsvar med eksempel 1 ble fremstilt: Three skin solutions in accordance with example 1 were prepared:
1. 1 % forbindelse A 1. 1% compound A
2. 0,5% forbindelse A 2. 0.5% compound A
3. 0,25% forbindelse A 3. 0.25% compound A
En placebo ble fremstilt, som skilte seg fra hud-oppløsningene i samsvar med oppfinnelsen ved at den ikke inneholdt noe forbindelse A. A placebo was prepared which differed from the skin solutions according to the invention in that it contained no compound A.
I undersøkelsene ble 1 ml hud-oppløsning eller av placebo anvendt pr. 10 kg vekt av dyr. In the investigations, 1 ml of skin solution or placebo was used per 10 kg weight of animal.
Dosevolumet ble tilført langs dyrets rygglinje, fra hodet til haleroten. The dose volume was administered along the animal's dorsal line, from the head to the root of the tail.
Mellom dager -24 og -1, ble dyrene kunstig infisert 11 ganger med 2500 Boophilus microplus larver. Målet med 24-dager infisering er å sikre at alle trinnene av Boophilus microplus er tilstede på dyret (egg, larver, voksne). Between days -24 and -1, the animals were artificially infected 11 times with 2500 Boophilus microplus larvae. The aim of the 24-day infection is to ensure that all stages of Boophilus microplus are present on the animal (eggs, larvae, adults).
På dag 0 mottok dyrene en av hud-oppløsningene eller placebo. On day 0, the animals received one of the skin solutions or placebo.
Før hud-oppløsningene eller placebo tilføres telles antallet midd tilstede på de ulike dyrene i de forskjellige gruppene. Before the skin solutions or placebo are administered, the number of mites present on the different animals in the different groups is counted.
Den etterfølgende tabell indikerer de registrerte verdier, vekten til dyrene og dosen av hud-oppløsning eller av placebo som vil tilføres til hver av disse dyrene. The following table indicates the recorded values, the weight of the animals and the dose of skin solution or of placebo that will be administered to each of these animals.
De blodfylte hunn-midd som ble løsgjort er inkludert i tellingen. Resultatene er indikert i fig. 1. The blood-filled female mites that were detached are included in the count. The results are indicated in fig. 1.
En doseavhengig effekt oppnås med 100% virkningsfullhet for hud-oppløsningen i samsvar med oppfinnelsen inneholdende 1% forbindelse A. De mindre konsentrerte oppløsningene gir ikke desto mindre bemerkelsesverdige resultater. A dose-dependent effect is achieved with 100% effectiveness for the skin solution according to the invention containing 1% compound A. The less concentrated solutions nevertheless give remarkable results.
Den svært hurtige virkningen av oppløsningene i samsvar med oppfinnelsen bemerkes også, idet den 1% oppløsningen lar Boophilus microplus fjernes fullstendig i løpet av mindre enn 2 døgn. The very rapid action of the solutions according to the invention is also noted, as the 1% solution allows Boophilus microplus to be completely removed in less than 2 days.
Eksempel 3: Example 3:
Sammenligning av virkningsfullhet mellom en hud-oppløsning i samsvar med oppfinnelsen inneholdende 1% forbindelse A og en hud-oppløsning inneholdende 1% flumetrin. Comparison of effectiveness between a skin solution in accordance with the invention containing 1% compound A and a skin solution containing 1% flumethrin.
Dyr av den samme rase som dem i eksempel 1 ble anvendt. Animals of the same breed as those in Example 1 were used.
På dag 0 behandles gruppene med: On day 0, the groups are treated with:
hud-oppløsning inneholdende 1 % forbindelse A skin solution containing 1% compound A
hud-oppløsning inneholdende 1 % flumetrin (mineralolje og etylheksylalkohol-ekspipiens) placebo (eksipiens identisk med oppløsningen i samsvar med oppfinnelsen) skin solution containing 1% flumethrin (mineral oil and ethylhexyl alcohol excipient) placebo (excipient identical to the solution according to the invention)
Tabell 2 nedenfor indikerer for hver gruppe vekten av dyrene, den mottatte dose hud-oppløsning og den tilførte dose av aktiv substans. Table 2 below indicates for each group the weight of the animals, the dose of skin solution received and the dose of active substance administered.
Fra dag 2 til dag 32 mottok dyrene 5.000 Boophilus microplus larver tre ganger pr. uke. Fra dag 18 til 64 oppsamles og telles de blod-fylte hunn-midd som løsgjøres. From day 2 to day 32, the animals received 5,000 Boophilus microplus larvae three times per week. From day 18 to 64, the blood-filled female mites that are released are collected and counted.
Resultatene er indikert i fig. 2 og 3, som demonstrerer den totale virkningsfullhet av hud-oppløsningen i samsvar med oppfinnelsen. The results are indicated in fig. 2 and 3, which demonstrate the overall effectiveness of the skin solution in accordance with the invention.
Eksempel 4: Example 4:
Undersøkelse av virkningsfullhet over tid. Examination of effectiveness over time.
Hud-oppløsninger i samsvar med oppfinnelsen inneholdende 0,25, 0,5 eller 1% forbindelse A ble anvendt i dette eksempelet. Skin solutions according to the invention containing 0.25, 0.5 or 1% compound A were used in this example.
Sammensetningen av disse oppløsningene er den samme som for de foregående eksempler. The composition of these solutions is the same as for the preceding examples.
Kveget ble for-infisert for å ha alle trinnene av Boophilus microplus tilstede (infisering med 5.000 larver, 22 dager, 15 dager og 8 dager før tilføring av hud-oppløsningen). The cattle were pre-infected to have all stages of Boophilus microplus present (infection with 5,000 larvae, 22 days, 15 days and 8 days before application of the skin solution).
Etter tilføring av hud-oppløsningene infiseres kveget igjen med larvene i 13 uker, for å bestemme virkningsfullheten av de tre konsentrasjonene. After application of the skin solutions, the cattle are again infected with the larvae for 13 weeks, in order to determine the effectiveness of the three concentrations.
Resultatene er angitt i tabell 3 nedenfor: The results are set out in Table 3 below:
Det observeres således at det oppnås bemerkelsesverdig virkningsfullhet, som kan vare i to måneder eller mer. It is thus observed that remarkable effectiveness is achieved, which can last for two months or more.
Claims (15)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9604209A FR2746595B1 (en) | 1996-03-29 | 1996-03-29 | SKIN SOLUTION FOR DIRECT DEPOSIT FOR PEST CONTROL IN CATTLE AND SHEEP |
US69217896A | 1996-08-05 | 1996-08-05 | |
PCT/FR1997/000542 WO1997036486A1 (en) | 1996-03-29 | 1997-03-26 | Solution for direct application on the skin for controlling cattle and sheep parasites |
Publications (3)
Publication Number | Publication Date |
---|---|
NO975473D0 NO975473D0 (en) | 1997-11-27 |
NO975473L NO975473L (en) | 1998-01-29 |
NO324071B1 true NO324071B1 (en) | 2007-08-06 |
Family
ID=26232632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19975473A NO324071B1 (en) | 1996-03-29 | 1997-11-27 | Solution for direct application on the skin to control cattle and sheep parasites and their use. |
Country Status (20)
Country | Link |
---|---|
AT (2) | AT504042A1 (en) |
AU (1) | AU2513097A (en) |
BE (1) | BE1010483A5 (en) |
BR (1) | BR9702162A (en) |
CA (1) | CA2222675C (en) |
CH (1) | CH692894A8 (en) |
DE (1) | DE19780396B3 (en) |
DK (1) | DK177400B1 (en) |
ES (1) | ES2143389B1 (en) |
FI (1) | FI119042B (en) |
FR (1) | FR2747015B1 (en) |
GB (1) | GB2318512B (en) |
GR (1) | GR1002910B (en) |
IE (1) | IE970215A1 (en) |
IT (1) | IT1291699B1 (en) |
LU (1) | LU90177B1 (en) |
NL (1) | NL1005673C2 (en) |
NO (1) | NO324071B1 (en) |
SE (1) | SE523761C2 (en) |
WO (1) | WO1997036486A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW524667B (en) | 1996-12-05 | 2003-03-21 | Pfizer | Parasiticidal pyrazoles |
AUPQ441699A0 (en) * | 1999-12-02 | 2000-01-06 | Eli Lilly And Company | Pour-on formulations |
WO2001095723A1 (en) * | 2000-06-15 | 2001-12-20 | Ssl International Plc | Parasiticidal composition |
DE10063865A1 (en) * | 2000-12-21 | 2002-06-27 | Bayer Ag | Use of pyrazole oximes as parasiticides |
US7514464B2 (en) | 2003-12-18 | 2009-04-07 | Pfizer Limited | Substituted arylpyrazoles |
GB0329314D0 (en) | 2003-12-18 | 2004-01-21 | Pfizer Ltd | Substituted arylpyrazoles |
DE102006061537A1 (en) * | 2006-12-27 | 2008-07-03 | Bayer Healthcare Ag | Agent for controlling parasites on animals comprises an N-phenylpyrazole, an aliphatic cyclic carbonate and an aliphatic polyether |
TW200846029A (en) * | 2007-02-09 | 2008-12-01 | Wyeth Corp | High dose, long-acting ectoparasiticide for extended control |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3029426A1 (en) * | 1980-08-02 | 1982-03-11 | Bayer Ag, 5090 Leverkusen | AGAINST EFFECTIVE POUR-ON FORMULATIONS |
GB8531485D0 (en) * | 1985-12-20 | 1986-02-05 | May & Baker Ltd | Compositions of matter |
GB8713768D0 (en) * | 1987-06-12 | 1987-07-15 | May & Baker Ltd | Compositions of matter |
DE3719732A1 (en) * | 1987-06-12 | 1989-01-05 | Bayer Ag | SUBSTITUTED 5-METHYLAMINO-1-ARYLPYRAZOLE |
YU47834B (en) * | 1989-08-10 | 1996-01-09 | Schering Agrochemical Limited | THE AZOLE PESTICIDE |
NO179282C (en) * | 1991-01-18 | 1996-09-11 | Rhone Poulenc Agrochimie | New 1- (2-pyridyl) pyrazole compounds for control of insect pests |
GB9120641D0 (en) * | 1991-09-27 | 1991-11-06 | Ici Plc | Heterocyclic compounds |
GB9306184D0 (en) * | 1993-03-25 | 1993-05-19 | Zeneca Ltd | Heteroaromatic compounds |
DE4414333A1 (en) * | 1994-04-25 | 1995-10-26 | Bayer Ag | Substituted pyridylpyrazoles |
IL116147A (en) * | 1994-11-30 | 2002-05-23 | Aventis Cropscience Sa | Emulsifiable composition for the control of insects |
-
1997
- 1997-03-20 IE IE970215A patent/IE970215A1/en not_active IP Right Cessation
- 1997-03-26 AU AU25130/97A patent/AU2513097A/en not_active Abandoned
- 1997-03-26 WO PCT/FR1997/000542 patent/WO1997036486A1/en active IP Right Grant
- 1997-03-26 AT AT0900497A patent/AT504042A1/en not_active Application Discontinuation
- 1997-03-26 GR GR970100110A patent/GR1002910B/en not_active IP Right Cessation
- 1997-03-26 FR FR9703708A patent/FR2747015B1/en not_active Expired - Lifetime
- 1997-03-26 ES ES009750029A patent/ES2143389B1/en not_active Expired - Fee Related
- 1997-03-26 BR BR9702162A patent/BR9702162A/en active IP Right Grant
- 1997-03-26 GB GB9725003A patent/GB2318512B/en not_active Expired - Lifetime
- 1997-03-26 CA CA002222675A patent/CA2222675C/en not_active Expired - Lifetime
- 1997-03-26 DE DE19780396T patent/DE19780396B3/en not_active Expired - Lifetime
- 1997-03-26 CH CH02791/97A patent/CH692894A8/en not_active IP Right Cessation
- 1997-03-27 IT IT97TO000260A patent/IT1291699B1/en active IP Right Grant
- 1997-03-27 BE BE9700276A patent/BE1010483A5/en active
- 1997-03-27 NL NL1005673A patent/NL1005673C2/en not_active IP Right Cessation
- 1997-11-24 SE SE9704303A patent/SE523761C2/en not_active IP Right Cessation
- 1997-11-26 LU LU90177A patent/LU90177B1/en active
- 1997-11-27 NO NO19975473A patent/NO324071B1/en not_active IP Right Cessation
- 1997-11-27 FI FI974353A patent/FI119042B/en not_active IP Right Cessation
- 1997-11-27 DK DKPA199701363A patent/DK177400B1/en not_active IP Right Cessation
-
2009
- 2009-09-04 AT ATA1395/2009A patent/AT506843B1/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6010710A (en) | Direct pour-on skin solution for antiparasitic use in cattle and sheep | |
TWI494061B (en) | Local topical administration formulations containing indoxacarb | |
US6998131B2 (en) | Spot-on formulations for combating parasites | |
CA2865117C (en) | Topical compositions comprising fipronil and permethrin and methods of use | |
MX2007014346A (en) | Spot-on formulations for combating parasites. | |
US20020081327A1 (en) | Direct pour-on antiparasitic skin solution and methods for treating, preventing and controlling myasis | |
AT506843B1 (en) | DIRECTLY ADAPTABLE TO THE SKIN TO REMOVE PARASITES IN BOVINE ANIMALS AND SHEEP | |
CA2578079A1 (en) | Methoprene formulations for the control of tick infestations | |
JP2636880B2 (en) | Agricultural insecticide and acaricide with enhanced potency | |
JP2006502241A (en) | Nozrisporic acid derivative spot-on formulation for controlling parasites | |
AU2003257646B2 (en) | Direct pour-on skin solution for anitparasitic use in cattle and sheep | |
AU763484B2 (en) | Direct pour-on skin solution for antiparasitic use in cattle and sheep | |
DK178513B1 (en) | Insecticide combination preparation for use against mammalian blood mites, especially cats and dogs | |
MXPA97009092A (en) | Cutaneous solution for direct deposit intended for the elimination of parasites in cattle and sheep, use of a composite in such solution and treatment procedure for cattle and sheep with such solution | |
OA17083A (en) | Topical compositions comprising fipronil and permethrin and methods of use. | |
DE19961812A1 (en) | Use of at least one fatty acid polydialkanolamide in combination with quinic acid and / or shikimi acid for pest control |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CREP | Change of representative |
Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104 |
|
MK1K | Patent expired |